Ortabaş

Cem Ortabaş is a co-founder of HubX, a technology company renowned for developing highly scalable mobile applications that have achieved over 100 million users globally. In addition to this role, Cem serves as a board member at Urla Şarapçılık and is an investor in Biosplice Therapeutics, a biotech firm focused on creating regenerative medicines through the Wnt pathway, and Veloxia Technology. Cem's academic background includes a Bachelor of Business Administration from Koç University, followed by ongoing studies at Harvard Business School Online.